Well-Known Activist Shareholder Pushing For Sale Of Identiv - Identive Group, Inc. (NASDAQ:INVE) | Seeking Alpha

Well-Known Activist Shareholder Pushing For Sale Of Identiv - Identive Group, Inc. (NASDAQ:INVE) | Seeking Alpha

Scott Matusow Blog | Activist Shareholder David Callan Pushing For Sale Of Identiv | Talkmarkets

Scott Matusow Blog | Activist Shareholder David Callan Pushing For Sale Of Identiv | Talkmarkets

Scott Matusow Blog | Identiv Goes On The Record With Disney Infinity Toys | Talkmarkets

Scott Matusow Blog | Identiv Goes On The Record With Disney Infinity Toys | Talkmarkets

NFC Adoption By Apple Helps Pave The Way For Identiv - StockMatusow

NFC Adoption By Apple Helps Pave The Way For Identiv - StockMatusow

Author Board - Published | Seeking Alpha

Author Board - Published | Seeking Alpha

Identiv's Q2 Earnings Call Full Audio - Updated With YOY Numbers -

Identiv's Q2 Earnings Call Full Audio - Updated With YOY Numbers -

Public Video: Identiv DD And Basic View Of The Company + Some Trading And Investing Advice -

Public Video: Identiv DD And Basic View Of The Company + Some Trading And Investing Advice -

Identiv's Q2 Earnings Show Strong Growth - Acquisition Likely

Identiv's Q2 Earnings Show Strong Growth - Acquisition Likely

Identiv's (INVE) Q2 Earnings Call Full Audio -

Identiv's Q2 Earnings Call Full Audio -

Identiv's Q2 Earnings Show Strong Growth - Acquisition Likely At Some Point - Identive Group, Inc. (NASDAQ:INVE) | Seeking Alpha

Identiv's Q2 Earnings Show Strong Growth - Acquisition Likely At Some Point - Identive Group, Inc. (NASDAQ:INVE) | Seeking Alpha

Public Live Show, Every Friday at 4:15 PM Eastern |

Public Live Show, Every Friday at 4:15 PM Eastern |

Edelman's Perceptive Advisors Buying Amicus Therapeutics Ahead Of Phase III Data Release - Amicus Therapeutics, Inc. (NASDAQ:FOLD) | Seeking Alpha

Edelman's Perceptive Advisors Buying Amicus Therapeutics Ahead Of Phase III Data Release - Amicus Therapeutics, Inc. (NASDAQ:FOLD) | Seeking Alpha

AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month - AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) | Seeking Alpha

AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month - AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) | Seeking Alpha

Activist Investor David Callan Accumulating Identiv Stock | Investing.com

Activist Investor David Callan Accumulating Identiv Stock | Investing.com

Membership Options

Membership Options For research reports, audio chat, catalyst trades, education, and investment thesis, see Premium Membership Options http://stockmatusow.com/membership-options/

Activist Investor David Callan Has Been Accumulating Identiv Stock, Here's Why - Identive Group, Inc. (NASDAQ:INVE) | Seeking Alpha

Activist Investor David Callan Has Been Accumulating Identiv Stock, Here's Why - Identive Group, Inc. (NASDAQ:INVE) | Seeking Alpha

The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming | Seeking Alpha

The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming | Seeking Alpha

Progenics Phase II Poster Data From Saturday At ASCO

Progenics Phase II Poster Data From Saturday At ASCO

Progenics Pharma Poised For A Potential Price Increase Ahead Of June 11 Adcom - Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) | Seeking Alpha

Progenics Pharma Poised For A Potential Price Increase Ahead Of June 11 Adcom - Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) | Seeking Alpha

Progenics Pharmaceuticals Inc. PGNX : Progenics Chart Shows Break Out Might Be Coming

Progenics Pharmaceuticals Inc. PGNX : Progenics Chart Shows Break Out Might Be Coming

Updated: Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why

Updated: Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why



Orexigen's Weight Loss Drug Will Be Approved Soon And Lead Market - Here Is Why http://stockmatusow.com/orexigens-weight-loss-drug-will-approved-soon-will-lead-market (Was Premium Content, Now Free) $IBB

Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why - Orexigen Therapeutics, Inc. (NASDAQ:OREX) | Seeking Alpha

Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why - Orexigen Therapeutics, Inc. (NASDAQ:OREX) | Seeking Alpha

Cytokinetics, Inc. (CYTK) news: Cytokinetics Binary Failure Provides Solid Buying Opportunity - Seeking Alpha

Cytokinetics, Inc. (CYTK) news: Cytokinetics Binary Failure Provides Solid Buying Opportunity - Seeking Alpha

Commentary And Charts For March 18, 2014 (Premium Content)

Commentary And Charts For March 18, 2014

Following The Smart Money: The Small Cap Biotech Investments Of Randal J. Kirk - Seeking Alpha

Following The Smart Money: The Small Cap Biotech Investments Of Randal J. Kirk - Seeking Alpha

Free Preview Video: Charts and Commentary For Feb. 27, 2014

Free Preview Video: Charts and Commentary For Feb. 27, 2014

Xenoport, Inc. XNPT : $XNPT Chart indicators = Bullish

Xenoport, Inc. XNPT : $XNPT Chart indicators = Bullish

Significant Upcoming Catalysts For These Biotechs Should Provide Alpha Opportunity - Seeking Alpha

Significant Upcoming Catalysts For These Biotechs Should Provide Alpha Opportunity - Seeking Alpha

Baker Brothers’ Holding Cerus Flying Under The Radar With Catalyst Upcoming

Baker Brothers’ Holding Cerus Flying Under The Radar With Catalyst Upcoming

Cerus Corporation (CERS) news: Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming - Seeking Alpha

Cerus Corporation (CERS) news: Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming - Seeking Alpha

Zeltiq Aesthetics Inc (ZLTQ): Sell Watch: Zeltiq Has Become Over-Speculated - Seeking Alpha

Zeltiq Aesthetics Inc (ZLTQ): Sell Watch: Zeltiq Has Become Over-Speculated - Seeking Alpha

Trade Call Alert: We bought $NTWK Target opinion – $7.40

Trade Call Alert: We bought $NTWK Target opinion – $7.40

Free Preview Video: Market Wrap Up and Commentary For Jan. 14th, 2014

Free Preview Video: Market Wrap Up and Commentary For Jan. 14th, 2014

Synergy Pharmaceuticals, Inc. SGYP : $SGYP - Bullish Chart Indicators Review

Synergy Pharmaceuticals, Inc. SGYP : $SGYP - Bullish Chart Indicators Review

$SGYP - Bullish Chart Indicators Review - YouTube

$SGYP - Bullish Chart Indicators Review - YouTube

Small Cap BioPharmas With Near-Term Catalysts [Amarin Corporation plc (ADR), Celldex Therapeutics, Inc., Venaxis Inc, Salix Pharmaceuticals, Ltd.] - Seeking Alpha

Small Cap BioPharmas With Near-Term Catalysts [Amarin Corporation plc (ADR), Celldex Therapeutics, Inc., Venaxis Inc, Salix Pharmaceuticals, Ltd.] - Seeking Alpha

Synergy Pharmaceuticals Inc (SGYP): BioPharma Catalyst And Investment Pick In Focus: Synergy Pharma - Seeking Alpha

Synergy Pharmaceuticals Inc (SGYP): BioPharma Catalyst And Investment Pick In Focus: Synergy Pharma - Seeking Alpha

BioPharma Catalyst And Investment Pick In Focus Synergy Pharma

BioPharma Catalyst And Investment Pick In Focus Synergy Pharma